Genscript Biotech Corporation (1548.HK) HKSE
14.48
+2.34(+19.28%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.46B |
| Enterprise Value | 3.81B |
| P/E Ratio | -6.34 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 3.53 |
| Price/Book Ratio | 0.85 |
| Enterprise/Revenue | 3.89 |
| Enterprise/EBITDA | 11.76 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.56 |
| Operating Margin | 0.27 |
Management Effectiveness
| Return On Assets | -0.11 |
| Return On Equity | -0.13 |
Income Statement
| Revenue | 959.53M |
| Revenue/Share | 0.44 |
| Gross Profit | 553.2M |
| EBITDA | 317.61M |
| Net Income | -532.83M |
| Diluted EPS | -0.25 |
Balance Sheet
| Total Cash | 843.01M |
| Total Cash/Share | 0.39 |
| Total Debt | 523.15M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 1.47 |
| Book Value Per Share | 1.82 |
Price History
| 52-Week Change | -2.57 |
| 52-Week High | 19.4 |
| 52-Week Low | 10.36 |
| Moving Average 50 Days | 13.13 |
| Moving Average 200 Days | 14.28 |
Statistics
| Average Volume | 10.96M |
| Shares Outstanding | 2.18B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
